Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2026-02-28 @ 2:50 AM
Study NCT ID:
NCT02142335
Status:
UNKNOWN
Last Update Posted:
2014-05-20
First Post:
2014-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
Sponsor:
California Cancer Assocaties for Research & Excellence
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-03
Completion Date Type:
ESTIMATED
First Submit Date:
2014-03-25
First Submit QC Date:
None
Study First Post Date:
2014-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-16
Last Update Post Date:
2014-05-20
Last Update Post Date Type:
ESTIMATED